Institut Hospital del Mar d'Investigacions Mèdiques   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Barcelona Spain (1992)

Organization Overview

First Clinical Trial
2003
NCT01447472
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

IMIM (Hospital del Mar Medical Research Institute) | Parc de Salut Mar

Active Ingredients

Drugs in Phase 4 Trials (16)

denosumab (prolia) (1 trial)

estrogen (1 trial)

ferric carboxymaltose (Injectafer) (1 trial)

ferrous sulfate (1 trial)

follitropin alfa (1 trial)

incobotulinumtoxinA (Xeomin) (1 trial)

levobupivacaine (chirocaine) (1 trial)

levosimendan (1 trial)

magnesium citrate (1 trial)

polyethylene glycol (2 trials)

pregabalin (lyrica) (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

sodium chloride (1 trial)

sodium picosulfate (1 trial)

somatropin (protropin) (2 trials)

vitamin c (2 trials)

Drugs in Phase 3 Trials (1)

l-epigallocatechin (6 trials)

Drugs in Phase 2 Trials (8)

beta-hydroxyisovaleric acid (1 trial)

caffeine (1 trial)

dextromethorphan (delsym) (1 trial)

losartan (cozaar) (1 trial)

omeprazole (prilosec) (1 trial)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (1 trial)

saccharomyces boulardii (1 trial)

Drugs in Phase 1 Trials (27)

anastrozole (arimidex) (1 trial)

budesonide (rhinocort) (1 trial)

bupropion (wellbutrin) (1 trial)

cannabis (1 trial)

chlorthalidone (Hygroton) (1 trial)

daidzoside (1 trial)

danazol (danocrine) (1 trial)

deflazacort (emflaza) (1 trial)

dexamethasone (1 trial)

epoetin (Epogen) (1 trial)

ethanol (6 trials)

fluconazole (diflucan) (1 trial)

green tea (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

hydromorphone (diladid) (1 trial)

leuprolide (lupron) (1 trial)

mdma (2 trials)

mephedrone (2 trials)

methylprednisolone (medrol) (1 trial)

nicotine (nicorette) (1 trial)

olive oil (1 trial)

red wine (1 trial)

salmeterol (serevent) (1 trial)

testosterone (delatestryl) (2 trials)

testosterone cyclopentylpropionate (1 trial)

triptorelin (Trelstar) (1 trial)

water (1 trial)

Drugs in Other Trials (20)

boceprevir (victrelis) (1 trial)

cefazolin (ancef) (1 trial)

daclatasvir (daklinza) (1 trial)

dasabuvir (Exviera) (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

lavender oil (2 trials)

ledipasvir (Harvoni) (1 trial)

ombitasvir (Viekira Pak) (1 trial)

oxygen (1 trial)

paritaprevir (viekira pak) (1 trial)

ribavirin (virazole) (1 trial)

ritonavir (Norvir) (1 trial)

simeprevir (olysio) (1 trial)

sofosbuvir (sovaldi) (1 trial)

spironolactone (aldactone) (1 trial)

telaprevir (incivek) (1 trial)

tyrosol (1 trial)

vanilla essential oil (1 trial)

vedolizumab (entyvio) (1 trial)

white wine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Drinking (Phase 1)

Alcohol-Related Disorders (Phase 1)

Amphetamine-Related Disorders (Phase 1)

Anemia (Phase 4)

Arthralgia (Phase 4)

Cancer Pain (Phase 4)

Clubfoot (Phase 4)

Cognition Disorders (Phase 2)

Cognitive Dysfunction (Phase 2)

Colonic Diseases (Phase 4)

Communicable Diseases (Phase 2)

Diabetes Mellitus (Phase 3)

Disease (Phase 1)

Down Syndrome (Phase 2)

Drug Overdose (Phase 2)

Fetal Alcohol Spectrum Disorders (Phase 3)

Heart Failure (Phase 4)

Hip Injuries (Phase 4)

Infections (Phase 2)

Infertility (Phase 4)

Marijuana Abuse (Phase 1)

Muscle Spasticity (Phase 4)

Musculoskeletal Pain (Phase 4)

Obesity (Phase 2)

Obesity, Morbid (Phase 2)

Osteoarthritis, Knee (Phase 4)

Osteoporosis (Phase 4)

Osteoporotic Fractures (Phase 4)

Overweight (Phase 2)

Pancreatic Neoplasms (Phase 4)

Prader-Willi Syndrome (Phase 4)

Sarcopenia (Phase 2)

Stroke (Phase 4)

Syndrome (Phase 3)

Tobacco Use Disorder (Phase 1)

Visceral Pain (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 54
  • # of Trial APIs: 72